Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Poster Presentations

GH & IGFs P2

Identification of Three Novel GLI2 Gene Variants Associated with Hypopituitarism
aUnidad de Endocrinología Pediátrica, Dpto Pediatría, Hospital Clinico Universitario de Santiago de Compostela, USC, IDIS, Santiago de Compostela, Spain; bUnidad de Medicina Molecular, Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain; cUnidad de Metabolopatías, Dpto de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain; dDpto de Pediatría, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
hrp0089p2-p206
Clinical and Preliminary Molecular Description of a Cohort of Patients with Growth Retardation due to Severe Primary IGF1 Deficiency (GROWPATI Study)
aPaediatric Endocrinology, Diabetology and Gynecology Department, Necker Children’s University Hospital, Paris, France; bINSERM U1163, IMAGINE Institute Affiliate and U1016, Cochin Institute, Paris, France; cCentre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CMERCD), Paris, France; dParis Descartes University, Paris, France; eSorbonne Université, INSERM UMR S938, Centre de Recherche Saint-Antoine, Trousseau Hospital, Paris, France; fSorbonne Université, Université Pierre et Marie Curie, Université Paris 06, INSERM UMR S933, Trousseau Hospital, Genetics department, Paris, France
hrp0089p2-p207
A Novel, Synonymous, Heterozygous, Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor: Causality for Mild Growth Impairment and IGF-I Deficiency in an Affected Patient?
aDepartment of Pediatrics, Division of Endocrinology, Medical School, University of Patras, Patra, Greece; bDepartment of Biology Medical School, University of Patras, Patra, Greece; cDivision of Endocrinology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA
hrp0089p2-p208
A Novel Mutation of Type I Insulin-like Growth Factor Receptor (IGF1R) Gene in a Severe Short Stature Pedigree Identified by Targeted Next-generation Sequencing (NGS)
aDepartment of Endocrinology, Metabolism, and Genetics, Jiangxi Provincial Children’s Hospital, Nanchang, China; bCentral laboratory, Jiangxi Provincial Children’s Hospital, Nanchang, China
hrp0089p2-p209
Growth Hormone Treatment for Short Stature Associated with TRNT1 Deficiency: A Case Series
Baylor College of Medicine, Houston, USA; Texas Children’s Hospital, Houston, USA
hrp0089p2-p211
Case Report: Novel Case of Short Stature and Co-occurrence of SHOX Gene Mutation and Fanconi Anemia
aStaten Island University Hospital, Staten Island, USA; bDonald and Barbara Zucker School of Medicine, Hempstead, USA; cAmerican University of the Caribbean School of Medicine, St. Martin, Saint-Martin (French part), USA
hrp0089p2-p212
Different Genetic Causes of Short Stature in a Family
aDivision of Pediatrics Endocrinology, Department of Pediatrics, University of Lübeck, Lübeck, Germany; bDivision of Pediatrics Endocrinology, Department of Pediatrics, University of Leipzig, Leipzig, Germany; cInstitute of Human Genetics, University of Leipzig, Leipzig, Germany; dInstitute of Human Genetics, University of Lübeck, Lübeck, Germany
hrp0089p2-p213
Systematic Prospective Study of Eye Funduscopy Before and After Starting Treatment with Growth Hormone in 290 Patients
aChildren’s University Hospital Vall Hebron, Barcelona, Spain; bAutonomous University of Barcelona, Barcelona, Spain; cCruces University Hospital, Barakaldo, Spain
hrp0089p2-p215
The BSPED National GH Audit: Trends in Prescribing from 2013-2016
aThe University of Manchester, Hon Consultant Paediatric Endocrinologist, Royal Manchester Children’s Hospital, Manchester, UK; bUniversity of Glasgow, Glasgow, UK; cUniversity of Birmingham, Birmingham, UK
hrp0089p2-p217
The Rationale and Design of TransCon GH
aAscendis Pharma A/S, Copenhagen, Denmark; bAscendis Pharm Inc., Palo Alto, CA, USA
hrp0089p2-p218
Baseline Demographics of the TransCon GH Phase 3 heiGHt Trial
aAscendis Pharma A/S, Copenhagen, Denmark; bAscendis Pharma Inc., Palo Alto, CA, USA
hrp0089p2-p219
The ZOMATRIP Study: Four Year Combination Therapy of GH and GnRHa in Girls with a Short Predicted Adult Height During Early Puberty: Adult Height Outcome
aUniversity Hospital Antwerpen, Edegem, Belgium; bHôpital Universitaire des Enfants Reine Fabiola (HUDERF, Brussels, Belgium; cUniversity Hospital Ghent, Ghent, Belgium; dJessah Hospital, Hasselt, Belgium; eUniversity Hospital Liège, Liège, Belgium; fUniversity Hospital Brussels, Brussels, Belgium; gBESPEED, Brussels, Belgium; hPendoCon, Putte, Belgium
hrp0089p2-p220
Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)
aUniversity Children’s Hospital, Skopje, Republic of Macedonia, The Former Yugoslav; bMedical Faculty, Skopje, Republic of Macedonia, The Former Yugoslav
hrp0089p2-p221
Height Perception of Children with GH Deficiency: Influencing Factors and Links to Psychosocial Functioning
aDepartment of Endocrinology Growth and Development, Children’s Hospital ‘P. & A. Kyriakou’, Athens, Greece; bNational and Kapodistrian University, Athens, Greece; cDepartment of Medical Psychology, University of Hamburg-Eppendorf, Hamburg, Germany; dCenter for Research in Neuropsychology and Cognitive Behavioural Intervention (CINEICC), Faculty of Psychology and Educational Sciences of the University of Coimbra, Coimbra, Portugal; eNational and Kapodistrian University of Athens, Athens, Greece
hrp0089p2-p222
Factors Influencing Health Related Quality of Life in Children/Adolescents with GH Deficiency
aDepartment of Endocrinology Growth and Development, Children’s Hospital ‘P. & A. Kyriakou’, Athens, Greece; bNational and Kapodistrian University of Athens, ATHENS, Greece; cDepartment of Medical Psychology, University Medical Center, Eppendorf, Hamburg, Germany; dCenter for Research in Neuropsychology and Cognitive Behavioural Intervention (CINEICC), Faculty of Psychology and Educational Sciences of the University of Coimbra, Coimbra, Portugal
hrp0089p2-p224
Adherence to Treatment in Growth Hormone Deficient and Small for Gestational Age Patients Naive to EasypodTM in Mexico: Final Results of the EasypodTM Connect Observational Study (ECOS)
aHospital Ángeles Interlomas & Hospital Español, México City, Mexico; bHospital Español, México City, Mexico; cHospital de la Oca, Monterrey, Nuevo León, Mexico; dHospital Ángeles, Puebla, Puebla, Mexico; ePrivate Practice, Cancún, Quintana Roo, Mexico; fHospital Zambrano-Elion, Monterrey, Nuevo León, Mexico; gInstituto Nacional de Pediatría, México City, Mexico; hMerck S.A. de C.V., Naucalpan de Juárez, Mexico; iMerck KGaA, Darmstadt, Germany; jServicio de Pediatría Hospital ISSEMyM, Toluca, Estado de México, Mexico.
hrp0089p2-p226
Growth Pattern and Final Height Outcome in Children with Septo-optic Dysplasia and Isolated Hypopituitarism Treated with rhGH in a Single Centre
aLondon Centre for Paediatric Endocrinology and Diabetes at Great Ormond Street Children’s Hospital and University College London Hospitals, London, UK; bSection of Genetics and Epigenetics in Health and Disease, Genetics and Genomic Medicine Programme, University College London Great Ormond Street Hospital Institute of Child Health, London, UK
hrp0089p2-p227
Reliability of Clonidine Testing for the Diagnosis of Growth Hormone Deficiency in Children and Adolescents
aSSD Endocrinologia Pediatrica e Centro Screening Neonatale, Ospedale Pediatrico Microcitemico ‘A. Cao’, AO Brotzu, Cagliari, Italy; bDipartimento di Pediatria, Università Federico II, Napoli, Italy; cClinica Pediatrica, IRCCS G. Gaslini, Università di Genova, Genova, Italy; dUOC di Endocrinologia Pediatrica, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy
hrp0089p2-p228
Area under the Curve of Growth Hormone, An Additional Tool in Assessing Stimulation Test Results
aPediatric Endocrine Division, Assuta University Hospital, Ashdod, Israel; bBen-Gurion University, Beer-Sheba, Israel; cPediatric Department, Safra Children’s Hospital, Ramat Gan, Israel.
hrp0089p2-p229
Evaluation of Spontaneous Nocturnal GH Secretion: Noe Versus Two Consecutive Nights
Klinik für Kinder- und Jugendmedizin Klinikum Bremen Nord, Bremen, Germany
hrp0089p2-p230
Effects of Zinc, Magnesium and Vitamin B6 (ZMA) Supplementation on Serum IGF-I, IGFBP-3 and Testosterone Concentrations in Young Athletes
aRibeirao Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil; bSchool of Physical Education and Sports of Ribeirão Preto, Ribeirão Preto-SP, Brazil
hrp0089p2-p233
High Protein Nutritional Supplementation Increases Serum IGF-I Concentrations in Short Children with Low IGF-I
Linköping University, Department of Clinical and Experimental Medicine, Division of Pediatrics, Linköping, Sweden
hrp0089p2-p234
Hormonal Predictors of Growth Hormone Therapy Effectiveness in Children with Short Stature - Evidence from Neural Prediction Model for Final Height
aDepartment of Pediatric Endocrinology, Medical University of Lodz, Lodz, Poland; bDepartment of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland; cDepartment of Biostatistics and Translational Medicine Medical University of Lodz, Lodz, Poland; dDepartment of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
hrp0089p2-p235
Artificial Neural Networks for Prediction Final Height in Children with growth Hormone Deficiency
aDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation; bEndocrinology Research Centre, Moscow, Russian Federation
hrp0089p2-p236
Predictors of Poor Response to Growth Hormone Therapy in Children with Short Stature - Evidence from Neural Prediction Model for Final Height
aDepartment of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital, Research Institute, Lodz, Poland; bDepartment of Biostatistics and Translational Medicine Medical University of Lodz, Lodz, Poland; cDepartment of Pediatric Endocrinology, Medical University of Lodz, Lodz, Poland; dDepartment of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
hrp0089p2-p237